{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:17:22Z","timestamp":1788322642521,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.jad.2019.10.040","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T22:03:36Z","timestamp":1572645816000},"page":"118-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Dose increase of S-Adenosyl-Methionine and escitalopram in a randomized clinical trial for major depressive disorder"],"prefix":"10.1016","volume":"262","author":[{"given":"Hitoshi","family":"Sakurai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"L. Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"R. Tyrka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence H.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"I. Papakostas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Dording","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert S.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Cusin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ludington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Bernard-Negron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Fava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mischoulon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2019.10.040_bib0001","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/01.jcp.0000145339.45794.cd","article-title":"S-adenosyl-l-methionine (SAMe) as an adjunct for resistant major depressive disorder: an open trial following partial or nonresponse to selective serotonin reuptake inhibitors or venlafaxine","volume":"24","author":"Alpert","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.jad.2019.10.040_bib0002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000448661","article-title":"Morbidity in depressive disorders","volume":"86","author":"Baldessarini","year":"2017","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.jad.2019.10.040_bib0003","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/jnnp.53.12.1096","article-title":"Cerebrospinal fluid S-adenosylmethionine in depression and dementia: effects of treatment with parenteral and oral S-adenosylmethionine","volume":"53","author":"Bottiglieri","year":"1990","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.040_bib0004","doi-asserted-by":"crossref","first-page":"971","DOI":"10.4088\/JCP.10m06223blu","article-title":"The future of psychopharmacology of depression","volume":"71","author":"Chang","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.040_bib0005","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet Lond. Engl."},{"key":"10.1016\/j.jad.2019.10.040_bib0006","series-title":"Statistical Power Analysis For the Behavioral Sciences","author":"Cohen","year":"1988"},{"key":"10.1016\/j.jad.2019.10.040_bib0007","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1007\/s00213-014-3467-8","article-title":"Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals","volume":"231","author":"Crawford","year":"2014","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.jad.2019.10.040_bib0008","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/204649","article-title":"S-Adenosyl-l-Methionine augmentation in patients with stage II treatment-resistant major depressive disorder: an open label, fixed dose, single-blind study","volume":"2013","author":"De Berardis","year":"2013","journal-title":"Sci. World J."},{"key":"10.1016\/j.jad.2019.10.040_bib0009","doi-asserted-by":"crossref","unstructured":"De Berardis, D., Orsolini, L., Serroni, N., Girinelli, G., Iasevoli, F., Tomasetti, C., de Bartolomeis, A., Mazza, M., Valchera, A., Fornaro, M., Perna, G., Piersanti, M., Di Nicola, M., Cavuto, M., Martinotti, G., Di Giannantonio, M., 2016 . A comprehensive review on the efficacy of S-Adenosyl-l-methionine in major depressive disorder. CNS Neurol. Disord. Drug Targets15, 35\u201344. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26295824.","DOI":"10.2174\/1871527314666150821103825"},{"key":"10.1016\/j.jad.2019.10.040_bib0010","series-title":"Structured Clinical Interview For DSM-IV Axis I Disorders \u2013 Patient Edition (SCID I\/P)","author":"First","year":"1995"},{"key":"10.1016\/j.jad.2019.10.040_bib0011","series-title":"ECDEU Assessment Manual For Psychopharmacology, revised. DHEW Pub. No. (ADM)76-338","year":"1976"},{"key":"10.1016\/j.jad.2019.10.040_bib0012","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.040_othref0002","first-page":"1","article-title":"S-adenosyl-l-methionine for treatment of depression, osteoarthritis, and liver disease","volume":"64","author":"Hardy","year":"2003","journal-title":"Evid. Rep. Technol. Assess. (Summ.)"},{"key":"10.1016\/j.jad.2019.10.040_bib0014","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jad.2010.06.010","article-title":"Second-tier natural antidepressants: review and critique","volume":"130","author":"Iovieno","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2019.10.040_bib0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12264-016-0023-z","article-title":"S-adenosylmethionine administration attenuates low brain-derived neurotrophic factor expression induced by chronic cerebrovascular hypoperfusion or beta amyloid treatment","volume":"32","author":"Li","year":"2016","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.jad.2019.10.040_bib0016","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4088\/JCP.13m08591","article-title":"A double-blind, randomized, placebo-controlled clinical trial of S-adenosyl-l-methionine (SAMe) versus escitalopram in major depressive disorder","volume":"75","author":"Mischoulon","year":"2014","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.040_bib0017","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/164_2018_152","article-title":"Current role of herbal and natural preparations","volume":"250","author":"Mischoulon","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.jad.2019.10.040_bib0018","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1176\/ajp.152.10.1500","article-title":"Early nonresponse to fluoxetine as a predictor of poor 8-week outcome","volume":"152","author":"Nierenberg","year":"1995","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl 5","key":"10.1016\/j.jad.2019.10.040_bib0019","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4088\/JCP.8157su1c.04","article-title":"Evidence for S-adenosyl-l-methionine (SAM-e) for the treatment of major depressive disorder","volume":"70","author":"Papakostas","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.040_bib0020","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/appi.ajp.2009.09081198","article-title":"S-adenosyl methionine (SAMe) augmentation of serotonin reuptake inhibitors for antidepressant nonresponders with major depressive disorder: a double-blind, randomized clinical trial","volume":"167","author":"Papakostas","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.040_bib0021","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1056\/NEJMcp1712493","article-title":"Depression in the primary care setting","volume":"380","author":"Park","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jad.2019.10.040_bib0022","doi-asserted-by":"crossref","first-page":"949","DOI":"10.4088\/JCP.10m06098","article-title":"Response rates to fluoxetine in subjects who initially show no improvement","volume":"72","author":"Posternak","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.040_bib0023","doi-asserted-by":"crossref","unstructured":"Rabkin, J.G., Markowitz, J.S., Ocepek-Welikson, K., Wager, S.S. General versus systematic inquiry about emergent clinical events with SAFTEE: implications for clinical research. J. Clin. Psychopharmacol. 12, 1992, 3\u201310. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/1552037.","DOI":"10.1097\/00004714-199202000-00002"},{"key":"10.1016\/j.jad.2019.10.040_bib0024","doi-asserted-by":"crossref","unstructured":"Rush, A.J., Gullion, C.M., Basco, M.R., Jarrett, R.B., Trivedi, M.H. The inventory of depressive symptomatology (IDS): psychometric properties. Psychol. Med. 26, 1996, 477\u2013486. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8733206.","DOI":"10.1017\/S0033291700035558"},{"key":"10.1016\/j.jad.2019.10.040_bib0025","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.040_bib0026","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.euroneuro.2018.07.098","article-title":"Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: an 8-week double-blind, randomized, controlled trial","volume":"28","author":"Sarris","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2019.10.040_bib0027","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1176\/appi.ajp.2016.15091228","article-title":"Adjunctive nutraceuticals for depression: a systematic review and meta-analyses","volume":"173","author":"Sarris","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.040_bib0028","doi-asserted-by":"crossref","first-page":"e656","DOI":"10.4088\/JCP.16r11113","article-title":"as work group of the american psychiatric association council on research","volume":"78","author":"Sharma","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2019.10.040_bib0029","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000491093","article-title":"A novel strategy to identify placebo responders: prediction index of clinical and biological markers in the embarc trial","volume":"87","author":"Trivedi","year":"2018","journal-title":"Psychother. Psychosom."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719315988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032719315988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T01:31:55Z","timestamp":1759023115000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032719315988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":29,"alternative-id":["S0165032719315988"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2019.10.040","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose increase of S-Adenosyl-Methionine and escitalopram in a randomized clinical trial for major depressive disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2019.10.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}